http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005145819-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67f2bb9a79bd8433343ae221f81551cf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 |
| filingDate | 2003-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36688bf0856f9ff6f0e49300d4508e86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a0e8954b9e8ced4e733b34c109dc18 |
| publicationDate | 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005145819-A |
| titleOfInvention | Fluorescent contrast agent and extracorporeal fluorescent contrast method |
| abstract | PROBLEM TO BE SOLVED: To diagnose a tumor or cancer that emits fluorescence that has low toxicity and excellent water solubility and can be transmitted through a living tissue, and enables specific imaging of the tumor, cancer and / or blood vessels. An object of the present invention is to provide a fluorescent contrast agent and an extracorporeal fluorescent contrast method using the fluorescent contrast agent. A fluorescent contrast agent for diagnosing a tumor or cancer comprising at least one penta- or heptamethine cyanine dye having 3H-pyrrolopyridine having at least two acid groups in the molecule as at least one of its mother nucleus. . [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018043150-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2778161-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2778161-A4 |
| priorityDate | 2003-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.